ORPP logo

Prostate Cancer : (Record no. 45311)

MARC details
000 -LEADER
fixed length control field 11414nam a22005653i 4500
001 - CONTROL NUMBER
control field EBC1910141
003 - CONTROL NUMBER IDENTIFIER
control field MiAaPQ
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729123323.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240724s2014 xx o ||||0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781617051067
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781936287598
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC1910141
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL1910141
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr11012595
035 ## - SYSTEM CONTROL NUMBER
System control number (CaONFJC)MIL687731
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)899158351
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC280.P7
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99/463
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dicker, Adam P.
245 10 - TITLE STATEMENT
Title Prostate Cancer :
Remainder of title A Multidisciplinary Approach to Diagnosis and Management.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Springer Publishing Company, Incorporated,
Date of production, publication, distribution, manufacture, or copyright notice 2014.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2014.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (438 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Current Multidisciplinary Oncology Series
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Cover -- Title -- Copyright -- Contents -- Contributors -- Series Foreword -- Preface -- Acknowledgments -- Share Prostate Cancer: A Multidisciplinary Approach to Diagnosis and Management -- Part I: Epidemiology, Screening, and Diagnosis -- Chapter 1: Introduction: The Multidisciplinary Approach to Prostate Cancer -- Prostate Cancer in the 20th Century -- Prostate Cancer in the 21st Century -- Prostate Cancer Patient Descision Making -- The Multidisciplinary Approach to Prostate Cancer -- Experience with the Multidisciplinary Approach to Prostate Cancer -- Conclusions -- References -- Chapter 2.1: Epidemiology of Prostate Cancer -- Introduction -- Global Burden of Prostate Cancer -- Established Risk Factors for Total Prostate Cancer Incidence -- Overview of Potential Risk Factors for Lethal Prostate Cancer -- Summary -- References -- Chapter 2.2: Diet and Prostate Cancer -- Introduction -- The Variable Course of Prostate Cancer -- Nutritional Components of the Diet -- Obesity as a Marker of Energy Imbalance -- Issues for Future Research -- References -- Chapter 2.3: Epidemiology: Obesity as a Risk Factor -- Introduction -- Obesity and PC Incidence -- Obesity and PC Treatment -- Obesity and PC-Specific Mortality -- Conclusions -- References -- Chapter 3.1.1: Screening and Diagnosis: The Pros of PSA Screening -- References -- Chapter 3.1.2: The Argument Against Prostate Cancer Screening -- A Brief History -- Does PSA Screening Find Localized Prostate Cancer? -- Does Treatment of Localized Disease Save Lives? -- Does Screening Prevent Death From Prostate Cancer? -- A Comparison of Populations -- The Prospective Randomized Trials -- Applying Clinical Studies to the Real World -- Summary -- References -- Chapter 3.1.3: How Do We Improve PSA Accuracy? -- Introduction -- PSA Cutoff Threshold -- Percent of Free PSA (%FPSA) -- PSA Velocity -- PSA Density.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Individualized Predicting Tools for Prostate Cancer -- Guidelines by American Urological Association -- Conclusions -- References -- Chapter 3.2: Screening and Diagnosis: An Update on the ISUP-Modified Gleason Score and Its Controversies -- Gleason Scoring System-A Brief History -- The Need to Update the System -- 2005 ISUP Consensus Conference and Subsequent Modifications -- Issues Relating Specifically to Needle Biopsies and Radical Prostatectomy Specimens -- Implications and Results of the ISUP-Modified Gleason Grading System -- Lingering Problems of the Gleason Grading System -- Is it Time for a Modified Grouping of Gleason Scores for Prognostic Studies? -- Conclusions -- References -- Chapter 3.3: Evaluation of Distant Disease: The Utility of Nuclear Imaging -- Introduction -- 18F-FDG -- 18F-Sodium Fluoride -- Choline: 18F-Choline and 11C-Choline -- Acetate: 11C-Acetate -- Amino Acids: 11C-Methionine and 18F-FACBC -- 18F-FDHT -- Prostate-Specific Membrane Antigen-Targeted Pet Agents -- HER2 -- Conclusion -- References -- Chapter 4: Current Approaches to Prostate Cancer Staging and Risk Stratification: In the Midst of a Paradigm Shift -- Introduction -- Clinical Staging for Initial Diagnosis and Treatment -- Molecular and Genomic Modalities: Improving Prognostic Precision -- Conclusion -- References -- Chapter 5.1: Novel Molecular and Genotype Profiling in Prostate Cancer: The Future of Screening, Diagnosis, and Staging -- Introduction -- A Role for Genomic-Based Biomarkers in Screening, Disease Diagnosis and Classification, and Clinical Treatment Decision Making -- Current Challenges and Opportunities in Prostate Cancer Screening -- Current Challenges and Opportunities in Prostate Cancer Diagnosis -- Current Challenges and Opportunities in Prostate Cancer Risk Stratification -- The Future of Molecular Screening and Staging Methods -- References.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Chapter 5.2: Genomics and Risk Assessment -- Introduction -- Current System of Risk Assessment and the Need for Integrating Genomic Data -- Different Technologies to Obtain Genomic Data -- Existing Genomic Data that can be Integrated into Risk Assessment -- Future Perspective -- Conclusion -- References -- Chapter 5.3: Future Direction: Novel Urine and Serum Markers -- Blood-Based Markers -- Urine-Based Markers -- Conclusions -- References -- Chapter 5.4: Morphometric and Systems Pathology: The Future of Screening, Diagnosis, and Staging -- Introduction -- Future of Screening and Diagnosis -- Treatment, Staging, and the Application of Risk Stratification through Systems "Precise" Pathology -- Systems "Precise" Pathology Platform -- Conclusions -- References -- Chapter 5.5.1: PET: The Future of Screening, Diagnosis, and Staging for Prostate Cancer -- Introduction -- F-18-FDG -- Future Directions -- References -- Chapter 5.5.2 DCE MRI and MR Spectroscopy: The Future of Screening, Diagnosis, and Staging -- DCE MRI -- MR Spectroscopy -- Conclusion -- References -- Chapter 5.5.3: Future Direction: Contrast Ultrasound -- Introduction -- Color and Power Doppler US -- 3D US -- CEUS -- Elastography -- Future Directions -- Conclusion -- References -- Chapter 6: Counseling Patients With Clinically Localized, High-Risk Prostate Cancer -- Establishing Realistic Expectations -- Defining Clinically Localized, High-Risk Prostate Cancer -- Treatment Options -- Multidisciplinary Approach -- Summary -- References -- Part II: Treatment for Low-Risk, Localized Disease -- Chapter 7: Active Surveillance for Prostate Cancer: An Overview -- Evidence to Support the Active Surveillance Concept -- Patient Selection -- Strategy for Monitoring -- Outcomes -- References -- Chapter 8: Treatment of Low-Risk, Localized Prostate Cancer: A Holistic Approach With Diet -- Introduction.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Epidemiology of Prostate Cancer -- Pathophysiology of Prostate Cancer -- Impact of Food on Prostate Cancer -- Impact of Vitamins, Minerals, and Other Supplements on Prostate Cancer -- Impact of Anti-Inflammatory Agents -- Exercise, Meditation, and Prostate Cancer -- Summary -- References -- Chapter 9.1: Traditional Radical Prostatectomy -- Introduction -- Anatomy and Surgical Technique -- Outcomes and Complications -- Other Considerations -- Conclusions -- References -- Chapter 9.2: Laparoscopic Radical Prostatectomy: Techniques and Complications -- Summary -- Introduction -- Patient Selection and Preoperative Preparation -- Rationale for Transperitoneal Approach -- The Instruments -- Surgical Technique -- Postoperative Care -- Complications and Management -- Conclusions -- References -- Chapter 9.3: Robotic Radical Prostatectomy: The Thomas Jefferson University Experience -- Procedure -- Outcomes -- References -- Chapter 9.4: Surgical Training, Digital Capture, Virtual Reality, and the Future of Radical Prostatectomy -- Dual Console -- Digital Capture, Duplication, and the Internet -- Virtual Reality Simulation -- References -- Chapter 10.1.1: External Beam Radiation Therapy: Conventional Fractionation -- Introduction -- Pretreatment Evaluation of the Low-Risk Patient -- Clinical Trials -- Dose Escalation -- MD Anderson Cancer Center 93-002 -- Proton Radiation Oncology Group 95-09 -- Dutch Trial CKTO 6910 -- MRC RT01 Trial -- Genitourinary Tumor Group (GETUG) -- IMRT and IGRT -- Hypofractionation and SBRT -- Toxicity of Radiation Therapy -- Second Malignancies -- Conclusions -- References -- Chapter 10.1.2: Hypofractionated Radiation Therapy for Localized Prostate Cancer -- Overview -- Background to Dose-Escalated Conventionally Fractionated Radiation Therapy -- Rationale Behind Hypofractionated Radiation Therapy.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Initial Trials Comparing CFRT and HFRT -- Modern Trials Comparing CFRT and HFRT -- Limitations and Future Direction -- Conclusions -- References -- Chapter 10.1.3: Stereotactic Body Radiation Therapy for Localized Prostate Cancer -- Overview -- Background and History of Increasing Dose Per Fraction -- Potential Benefits of SBRT -- Outcomes -- Toxicity -- Conclusion -- References -- Chapter 10.1.4: Treatment of Low-Risk, Localized Prostate Cancer: Use of Proton Therapy -- Introduction -- Basics of Proton Therapy -- Comparative Effectiveness of Proton Therapy -- Role for Multidisciplinary Care -- References -- Chapter 10.2: Treatment of Low-Risk, Localized Prostate Cancer: Brachytherapy -- LDR and HDR for Low-Risk Prostate Cancer -- Rationale for Brachytherapy in Low-Risk Disease -- Patient Selection with Low-Risk Disease -- Technical Issues -- Oncologic Issues -- Clinical Issues -- Results -- Toxicity -- References -- Chapter 11.1: Treatment of Low-Risk, Localized Prostate Cancer: General Principles of Ablative and Focal Therapies -- Introduction -- Patient Selection -- Treatment Modalities -- Follow-Up -- Conclusions -- References -- Chapter 11.2: Hyperthermia for Prostate Cancer -- References -- Chapter 11.3: Ablative Techniques: Vascular Targeted Photodynamic Therapy -- Mechanism of Action -- Delivery -- Clinical Trials: Safety and Efficacy -- Future Steps -- References -- Chapter 11.4: Laser Ablative Techniques for Prostate Cancer -- Mechanism of Action -- Delivery -- Clinical Trials -- Future Steps -- References -- Chapter 11.5: Irreversible Electroporation (IRE) Prostate Ablation -- Mechanism of Action -- Delivery -- IRE Experience-Prostate -- Future Steps -- References -- Chapter 12.1: Quality of Life With Surgery -- Introduction -- Erectile Dysfunction -- Urinary Incontinence.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Robotic-Assisted Radical Prostatectomy (RARP) Versus Retropubic Radical Prostatectomy (RRP).
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on publisher supplied metadata and other sources.
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prostate -- Cancer -- Diagnosis.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kelly, William Kevin.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thomas, Charles R., Jr.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Trabulsi, Edouard J.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zaorsky, Nicholas G.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Dicker, Adam P.
Title Prostate Cancer
Place, publisher, and date of publication New York : Springer Publishing Company, Incorporated,c2014
International Standard Book Number 9781936287598
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Current Multidisciplinary Oncology Series
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1910141">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=1910141</a>
Public note Click to View

No items available.

© 2024 Resource Centre. All rights reserved.